More News! 4 Dec 2023

FDA CAR-T cell therapy warning: Are T cells malignant?

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Innovent and IASO Bio obtain approval for CAR-T multiple myeloma treatment 

ADVERTISEMENT

Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer

Sponsored by 7 Feb 2023

Streamlining CAR-T cell therapy manufacturing: a platform approach

New biomarker for early prediction of response to CAR-T cell therapy

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma

Bioheng Biotech has positive CAR-T cell therapy results published in academic journal

World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China

Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors